Article Detail

Home > Article Detail
  • P-ISSN 2233-4203
  • E-ISSN 2093-8950

Diagnostic Evaluation of Enzyme Activity Related to Steroid Metabolism by Mass Spectrometry-Based Steroid Profiling

Mass Spectrometry Letters / Mass Spectrometry Letters, (P)2233-4203; (E)2093-8950
2014, v.5 no.2, pp.35-41
https://doi.org/10.5478/MSL.2014.5.2.35
Cho Man Ho (Korea Institute of Science and Technology)
Chung Bong Chul (Korea Institute of Science and Technology)
  • Downloaded
  • Viewed

Abstract

Gas chromatography-mass spectrometry (GC-MS) methods have been used extensively in clinical steroid analyses. Evaluating the metabolic ratios of precursors to products by accurate quantification of individual steroid levels in biologicalsamples can reveal the activities of enzymes associated with steroid metabolism. This review article discusses the impact of GCMS-based steroid profiling on our understanding of the biochemical role of steroids and their metabolic enzymes in hormonedependentdiseases, such as congenital adrenal hyperplasia (CAH), cortisol-mediated hypertension, apparent mineralocorticoidexcess (AME), male-pattern baldness, and breast and thyroid cancers. Steroid profiling is a comprehensive analytical techniquethat can be applied whenever the highest specificity is required and may be a reasonable initial diagnostic approach.

keywords
steroid, metabolite profiling, biomarker, clinical diagnosis, steroidogenesis


Reference

1

Caulfield, M. P.. (2002). . J. Clin. Endocrinol. Metabol, 87, 3682-.

2

Minutti, C. Z.. (2004). . J. Clin. Endocrinol. Metabol, 89, 3687-.

3

White, P. C.. (1997). . Endo. Rev, 18, 135-.

4

Choi, M. H.. (2002). . Clin. Chim. Acta, 320, 95-.

5

Randall, V. A.. (1992). . J. Invest. Dermatol, 98, 86S-.

6

Choi, M. H.. (2001). . J. Invest. Dermatol, 116, 57-.

7

Baglietto, L.. (2010). . Cancer Epidemiol. Biomarkers Prev, 19, 492-.

8

Choi, M. H.. (2011). . J. BMC Cancer, 11, 342-.

9

Liu, W.. (2013). . J. Lipid Res, 54, 244-.

10

Son, H. H.. (2014). . J. Lipid Res, 55, 155-.

11

Moon, J. Y.. (2014). . J. Steroid Biochem. Mol. Biol, 141, 52-.

12

Kölsch, H.. (2004). . Neurosci. Lett, 368, 303-.

13

Shobob, L. A.. (2005). . Lancet Neurol, 4, 841-.

14

Karasinska, J. M.. (2011). . Nat. Rev. Neurol, 7, 561-.

15

Moon, J. Y.. (2009). . J. Am. Soc. Mass Spectrom, 20, 1626-.

16

Sharpe, L. J.. (2013). . J. Biol. Chem, 288, 18707-.

17

Xu, X.. (2007). . Nat. Protocol, 2, 1350-.

18

Cho, H. J.. (2009). . Anal. Chim. Acta, 632, 101-.

19

Riepe, F. G.. (2007). . Rev. Endocr. Metab. Disord, 8, 349-.

20

Wudy, S. A.. (1995). . Pediatr. Res, 38, 76-.

21

Wudy, S. A.. (2000). . Horm. Res, 53, 68-.

22

Lai, C. C.. (2002). . J. Clin. Lab Anal, 16, 20-.

23

Wong, T.. (1992). . Clin. Chem, 38, 1830-.

24

Kaddurah-Daouk, R.. (2008). . Annu. Rev. Pharmacol. Toxicol, 653, 48-.

25

Holst, J. P.. (2007). . Steroids, 72, 71-.

26

Sahin, Y.. (1997). . Eur. J. Endocrinol, 137, 670-.

27

Rauh, M.. (2009). . Mol. Cell. Endocrinol, 301, 272-.

28

Sun Ju Kim. (2011). Screening Analysis of 10 Adrenal Steroids by Matrix-Assisted Laser Desorption Ionization-Tandem Mass Spectrometry. Mass Spectrometry Letters, 2(3), 69-72.

29

Raff, H.. (1987). . Am. J. Physiol, 252, R635-.

30

Stewart, P. M.. (1996). . Lancet, 347, 88-.

31

Palermo, M.. (1996). . Clin. Endocrinol, 45, 605-.

32

Mantero, F.. (1996). . Steroids, 61, 193-.

33

Ferrari, P.. (2000). . Kideny Int, 57, 1374-.

34

Walker, B. R.. (1997). . J. Clin. Endocrinol. Metabol, 82, 4015-.

35

Sawaya, M.. (1991). . Ann. N. Y. Acad. Sci, 642, 376-.

36

Sinclair, R.. (1998). . Br. Med. J, 317, 865-.

37

Randall, V. A.. (1994). . Clin. Endocrinol, 40, 439-.

38

Sawaya, M. E.. (1997). . J. Invest. Dermatol, 109, 296-.

39

Hibberts, N. A.. (1998). . J. Endocrinol, 156, 59-.

40

Phillipou, G. Kirk. (1981). . J. Clin. Exp. Dermatol, 6, 53-.

41

Choi, M. H.. (1999). . Analyst, 124, 1297-.

42

Jung, H. J.. (2011). . Rapid Commun. Mass Spectrom, 25, 1184-.

43

Choi, M. H.. (2014). . J. Invest. Dermatol, 20, 1626-.

44

Ross, R. K.. (1992). . Lancet, 339, 887-.

45

Pettaway, C. A.. (1999). . J. Natl. Med. Assoc, 91, 653-.

46

Hoffman, R.. (2000). . Eur. J. Dermatol, 10, 410-.

47

Eliassen, A. H.. (2008). . Cancer Epidemiol. Biomarkers Prev, 17, 2029-.

48

Arslan, A. A.. (2009). . Cancer Epidemiol. Biomarkers Prev, 18, 2273-.

49

Liehr, J. G.. (1996). (3294-). Proc. Natl. Acad. Sci. USA.

50

Castagnetta, L. A. M.. (2002). . Clin. Cancer Res, 8, 3146-.

51

Moon, J. Y.. (2013). . BMC Clin. Pathol, 13, 25-.

52

Choi, M. H.. (2011). . J. BMC Cancer, 11, 342-.

Submission Date
2014-05-27
Revised Date
2014-06-05
Accepted Date
2014-06-05
상단으로 이동

Mass Spectrometry Letters